Tyra Biosciences, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.02M-0.02M-0.05M-0.04M
Gross Profit -0.02M-0.02M-0.05M-0.04M
Operating items
Research & Development 7.20M20.64M43.01M62.52M
Selling, General & Administrative 2.09M5.65M15.92M17.43M
Operating Expenses 9.30M26.29M58.93M79.94M
Operating Income -9.30M-26.29M-58.93M-79.94M
EBIT -9.30M-26.29M-58.93M-79.94M
Non-operating items
Interest & Investment Income -0.00M0.01M3.65M10.85M
Non Operating Income -0.04M-0.01M3.60M10.81M
Net income details
EBT -9.32M-26.29M-55.33M-69.13M
Profit After Tax -9.34M-26.29M-55.33M-69.13M
Income from Continuing Operations -9.32M-26.29M-55.33M-69.13M
Consolidated Net Income -9.32M-26.29M-55.33M-69.13M
Income towards Parent Company -9.32M-26.29M-55.33M-69.13M
Net Income towards Common Stockholders -9.32M-26.29M-55.33M-69.13M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 39.12M41.27M42.20M43.06M50.60M
EBITDA -9.30M-26.29M-55.33M-68.75M